Revolution Medicines’ experimental cancer pill boosts survival in late-stage study Reuters Nawigacja wpisu One in 10 people may have resistance to GLP-1 diabetes drugs – Stanford Medicine New drug doubles 1-year survival in pancreatic cancer trial – Medical Xpress
